Tumori Journal - TJ
@tumorijournal.bsky.social
Tumori Journal #TJ is an international peer-reviewed journal that publishes updates in #oncology thanks contributions by opinion leaders and emerging researchers. #OncSky #MedSky https://journals.sagepub.com/home/TMJ
🆕The Process Mining is a methodological framework for analysing care pathways: it is a powerful approach for analysing and optimising complex workflows. #Radiationtherapy involves multiple steps and resources, making it well suited for PM analysis. journals.sagepub.com/share/CCRTY8... #RadOc
Discover an inspiring perspective on interdisciplinary approaches to CAR-T cell therapies in this episode of #TJTalks with Professor Yael David, Head of the laboratory and associate member of the Programme in Chemical Biology at #MSKCancerCenter and Dr Francesca De Santis. omny.fm/shows/tumori...
👉Multiparametric Whole-Body Magnetic Resonance Imaging (WB-MRI) may enhance bone metastasis detection in metastatic #breastcancer (mBC) patients. This is what emerges from the preliminary results of a prospective clinical trial in #TJ 🔓 journals.sagepub.com/doi/full/10.... #CanSky #RadOnc
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
journals.sagepub.com
🆕This study provides an innovative technological framework and preclinical evidence supporting localized mRNA-based #immunotherapy for #bladdercancer. 🔗https://journals.sagepub.com/share/5YFXQYE3FJZFSKNMTDFT?target=10.1177/03008916261463130 #genitourinarycancer #CanSky #OncoSky
🌞🌜Circadian and circannual rhythms act as silent determinants of cancer prognosis, influencing interaction between host’s immune system and tumour behaviour. Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC journals.sagepub.com/share/RBRQST...
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
🆕Does exist statistically significant difference between cisplatin- and carboplatin-based CT-IT in #lungcancer❓ Learn more on this systematic review providing separate outcome data for #carboplatin and #cisplatin. 🔗 journals.sagepub.com/share/55FYJI... #canSky #OncoSky
🎙️TJ Talks podcasts are also available on Vumedi - the U.S. platform for medical videos and podcasts built exclusively for its 40,000+ oncologist members. ✍️ 💥Submit your idea for a new TJ Talks tumorijournal.org/contact-us/ All the TJ Talks podcasts ➡️ tumorijournal.org Vumedi ➡️ vumedi.com
🎙️#TJTalks | Looking forward to the future... Dr. Francesco Pignatti, Scientific advisor for Oncology in the Human Medicine Division of the European Medicines Agency, is the guest of this TJ Talks episode – led by dr. Luca Moscetti.
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
omny.fm
#AI | This study aimed to introduce the best artificial intelligence techniques developed for the detection and diagnosis of #breastcancer using microscopic images by fuzzy AHP-TOPSIS techniques 🔗https://t.co/kgmkhfZquF
🔬🩸#Liquidbiopsy | The study’s findings support the analytical validity and clinical utility of TruSight Oncology 500 ctDNA, demonstrating high concordance with the FDA-approved Guardant360 CDx in detecting actionable alterations in NSCLC patients progressing on targeted therapies. t.co/X3JZCo5ka5
🎙️#TJTalks The #BENCHISTA project aims to better understand the reasons behind international differences in paediatric cancer survival. Prof. Pritchard-Jones explains how the #BENCHISTA data could contribute to further improvements in survival outcomes for children with cancer. t.co/iE9MIsUQl6
#AdverseEvent 💥 Alectinib is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be well tolerated. #Gastrointestinal (#GI) perforation is an extremely rare but potentially life-threatening complication. 🔗 journals.sagepub.com/doi/full/10.... #CanSky #OncoSky
Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series - Margherita Piccinelli, Raffaele Squitieri, Rebecca Romanò, Silvia Marchesi, Giulia Montelatici, Camilla Damonte, Marta Brambilla, Teresa Beninato, Laura Mazzeo, Giulia Corrao, Marco Meazza Prina, Arsela Prelaj, Claudia Proto, Margherita Galassi, Filippo Guglielmo Maria De Braud, Giuseppe Lo Russo, Mario Occhipinti, Paolo Ambrosini, 2026
Background: Alectinib, a second-generation ALK inhibitor, is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be both effec...
journals.sagepub.com
💥#Sarcoma Awareness Month #CanSky To help clarify #palliative care needs, authors investigated discrepancies in end-of-life management b/w Pts with #sarcoma and those with common carcinomas, suggesting that patients with sarcoma may pose special challenges to end-of-life care. t.co/GPJ8W9VG9e
💥 Is it possible to rethink monitoring as a considered clinical decision, rather than as an automatic procedure❓ The authors contend that shifting toward evidence-based follow-up is a strategic move designed to reduce unnecessary interventions🏥 🔗 journals.sagepub.com/doi/epub/10.... #CanSky
#CanSky #EndOfLife #SupportiveCare #PalliativeCare #hospice #QualityOfLife 🎯 Allowing access to hospice services for selected patients receiving disease-modifying therapies may facilitate better symptom control and improve quality of life near the end of life. journals.sagepub.com/doi/epub/10....
Tumori Journal - TJ@tumorijournal.bsky.social · 3mo ago🎙️🆕 #BENCHISTA project aims to better understand the reasons behind international differences in paediatric cancer survival. Prof. Kathy Pritchard-Jones explains how the use of its data could contribute to further improvements in survival outcomes. @ucl.ac.uk omny.fm/shows/tumori...
#CanSKy | Alectinib, a second-generation ALK inhibitor, is used in 1°-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be well tolerated. #Gastrointestinal perforation is an extremely rare but potentially life-threatening complication. journals.sagepub.com/doi/full/10....
#PsyOnc |This study analyzed the role of physical symptoms, illness awareness, individual activities and social contexts on anxious/depressive symptoms and mental health in localized (LP) and advanced/metastatic (AMP) cancer patients. 🔗 journals.sagepub.com/doi/full/10....
#TJTalks | Precision oncology is a broad concept based on the study of the #genome of tumour cells, in this podcast Prof. Paolo Marchetti is interviewed by Prof. Giancarlo Pruneri. 🎙️ omny.fm/shows/tumori... #CanSky #OncoSky
Precision Oncology: Multidisciplinary Approach and Artificial Intelligence for Personalized Therapies - Tumori Journal
In this episode of TJ Talks, the guest is Professor Paolo Marchetti, a well-known expert in precision oncology in Italy, Full Professor of Medical Oncology at the University of Rome "La Sapienza",…
omny.fm
💥 Is it possible to rethink monitoring as a considered clinical decision, rather than as an automatic procedure? The authors contend that shifting toward personalized, evidence-based follow-up is a strategic move designed to reduce unnecessary interventions🏥 journals.sagepub.com/doi/full/10....
🎙️🆕 #BENCHISTA project aims to better understand the reasons behind international differences in paediatric cancer survival. Prof. Kathy Pritchard-Jones explains how the use of its data could contribute to further improvements in survival outcomes. @ucl.ac.uk omny.fm/shows/tumori...
Early Diagnosis as a Determinant of Childhood Cancer Survival: Insights from the BENCHISTA Project - Tumori Journal
The BENCHISTA – International Benchmarking of Childhood Cancer Survival by Tumor stage – project is a worldwide collaboration led by University College London (UCL) and Fondazione IRCCS Istituto…
omny.fm
🎙️Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by EMA is very important, especially in the context of personalized medicine. 🎧 omny.fm/shows/tumori... #CanSky #OncoSky
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
omny.fm
☢️ #AI development in the carbon ion #radiotherapy domain is in early stages but holds promise for reducing costs and improving treatment. 🎯This review aims to examine current landscape of AI in #CIRT and highlight future directions. journals.sagepub.com/doi/full/10.... #RadOnc #radiationoncology
🎙️ #TJTlaks Podcast omny.fm/shows/tumori...
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
omny.fm
Dr. Giovanni Leuzzi discusses #chronobiology as potential new dimension of precision medicine. 🕛 ☀️ 🍂 Biological processes such as immune responses, inflammation, and DNA repair follow daily and seasonal rhythms regulated by the body’s biological clock. youtu.be/A5oaCkUwxdw?... #LungCancer #LCSM
Chronobiology and inflammation in early-stage NSCLC: Beyond the Anatomical Paradigm
YouTube video by Tumori Journal
youtu.be
🕐☀️🍂Biological processes such as immune responses, inflammation, and DNA repair follow daily and seasonal rhythms regulated by the body’s biological clock. I 📽️Dr. Giovanni Leuzzi (Thoracic Surgeon) discusses #chronobiology as a potential new dimension of #precisionmedicine. ⏯️ youtu.be/A5oaCkUwxdw
Chronobiology and inflammation in early-stage NSCLC: Beyond the Anatomical Paradigm
Dr. Giovanni Leuzzi (Thoracic Surgeon, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) discusses chronobiology as a potential new dimension of precision medicine. Biological processes…
youtu.be
